Piper Sandler analyst Matthew O’Brien reiterated a Hold rating on Sight Sciences (SGHT – Research Report) today and set a price target of $5.50. The company’s shares closed yesterday at $3.89.
O’Brien covers the Healthcare sector, focusing on stocks such as Sight Sciences, Boston Scientific, and Insulet. According to TipRanks, O’Brien has an average return of 1.2% and a 45.67% success rate on recommended stocks.
Sight Sciences has an analyst consensus of Hold, with a price target consensus of $5.63.
See Insiders’ Hot Stocks on TipRanks >>
SGHT market cap is currently $189.3M and has a P/E ratio of -2.64.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sight Sciences (SGHT) Company Description:
Sight Sciences Inc is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. The company’s product portfolio features the OMNI Surgical System, a dually-indicated device that facilitates the performance of both trabeculotomy and viscoelastic delivery. The company’s non-surgical product portfolio consists of TearCare system which is commercially available for both ophthalmologists and optometrists.
Read More on SGHT:
- Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting
- Sight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR™ Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
- Sight Sciences announces large-scale MIGS data
- Needham medtech/diagnostics analysts hold analyst/industry conference call
- Sight Sciences price target lowered to $5 from $11 at Stifel
